Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease

Abstract Non-alcoholic fatty liver disease (NAFLD) affects 25% of the adult population globally. Since liver fibrosis is the most important predictor of liver-related complications in patients with NAFLD, identification of patients with advanced fibrosis among at-risk individuals is an important iss...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Katharine M. Irvine, Satomi Okano, Preya J. Patel, Leigh U. Horsfall, Suzanne Williams, Anthony Russell, Elizabeth E. Powell
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/3622a3451cc5424a98c6081d430e546b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!